AzTrials
AzTrials

Diabetes ComplicationsNCT05967923

Effectiveness of Shock Wave Therapy Versus Low Level Lazer Therapy in Diabetic Frozen Shoulder Patients.

A study testing Shock wave therapy, Low level lazer therapy and Routine physical therapy program in people with Diabetes Complications, run by South Valley University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients will be divided randomly into 3 groups. Read more about this study

Who is it for?
Ages 45 to 60 years
Conditions the study is for
Diabetes Complications
What is being tested?
Shock wave therapy, Low level lazer therapy and Routine physical therapy program
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
5 Jul 2023to 15 Nov 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • patients with diabetes mellitus.
  • patients with frozen shoulder due to diabetes mellitus.
  • patients age ranged between 45 and 60 years old.
  • cooperative patients.

Who cannot join

  • patients with un-controlled hypertension.
  • patients sensetive to shock wave or lazer irradiation.
  • Patients with infectious skin diseases.
  • un-cooperative patients.

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Shymaa yussuf abo zaid

    Cairo

    Shymaa Y Abo zaid, 01010941685 ext. 01091631018, shaymaayoussef397@gmail.com

    Shymaa Y Abo zaid, Doctoral

    Recruiting

Other trials in Egypt

About this study

Official title: Effectiveness of Shock Wave Therapy Versus Low Level Lazer Therapy in Diabetic

Patients will be divided randomly into 3 groups.

Read the detailed description

Patients will be allocated from out patient clinics of Qena university hospitals Then they will be randomly assigned to three groups, every one will contain 30 patients of both gender, with age range between 45 and 60 years old

Being tested
Shock wave therapy, Low level lazer therapy, Routine physical therapy program
Keywords
Diabetes, Frozen shoulder
Medical subject headings
Diabetes Complications, Diabetes Mellitus, Bursitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Shock wave therapyRadiation

    Also called Non

    Patients in this group will receive shock wave therapy once a week for four weeks in addition to routine physical therapy program.

  • Low level lazer therapyRadiation

    Also called Non

    Patients in this group will receive low level lazer therapy three times a week week for four weeks in addition to routine physical therapy program.

  • Routine physical therapy programOther

    Patients in this group will receive only routine physical therapy program three times a week for four weeks.

Study groups in NCT05967923
Study groupRoleWhat they receive
Group (a)ExperimentalPatients in this group will receive shock wave therapy once a week for four weeks in addition to routine physical therapy program.
Receives: Radiation: Shock wave therapy; Other: Routine physical therapy program
Group (b)ExperimentalPatients in this group will receive low level lazer therapy three times per week for four weeks in addition to routine physical therapy program.
Receives: Radiation: Low level lazer therapy; Other: Routine physical therapy program
Group (c)ExperimentalPatients in this group will receive only routine physical therapy program.
Receives: Other: Routine physical therapy program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Shoulder joint Pain

    By using visual analogue scale

    Measured: 4 weeks

  2. Range of motion of the shoulder

    Range of shoulder internal and external rotation and shoulder flexion

    Measured: 4 weeks

Secondary outcomes (1)
  1. Shoulder and hand disability

    By using quick DASH questionnaire

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Aug 2023
  2. Study start5 Jul 2023
  3. Primary completion15 Oct 2023 (estimated)
  4. Study completion15 Nov 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Group (a) Group (b) Group (c)
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05967923
Sponsor's protocol ID
P.T- ORTH-06/2023-516
Status last verified
Jul 2023
First submitted
15 Jul 2023
Last updated
1 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Shock wave therapy, Low level lazer therapy and Routine physical therapy program in people with Diabetes Complications, run by South Valley University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Shymaa Yussuf Abo zaid (01010941685 ext. 01091631018, shaymaayoussef397@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Shoulder joint Pain (time frame: 4 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in